Man Group
LKFT

Man Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Man Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41M Buy
80,209
+32,628
+69% +$1.08M ﹤0.01% 1498
2025
Q4 		$1.56M Buy
47,581
+11,384
+31% +$368K ﹤0.01% 1545
2025
Q3 		$1.25M Buy
+36,197
New +$1.16M ﹤0.01% 1588

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group's LKFT Position: Q1 2026 in Review

Man Group increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 69% in Q1 2026, buying an estimated $1.08M and bringing the position to 80,209 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

Man Group first reported a position in LKFT in Q3 2025 and has held it in 3 quarters since. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Man Group held 80,209 shares of Lakefront Biotherapeutics American Depositary Shares worth $2.41M as of Q1 2026.
  • Man Group bought 32,628 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $1.08M.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1498 holding.
  • Man Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2025 and has held it in 3 quarters since.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.